Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms

Dustin M. McCraw; John R. Gallagher; Audray K. Harris

doi:10.1128/CVI.00085-16

McCraw, Dustin M.; Gallagher, John R.; Harris, Audray K.

2016-06-01 00:00:00

Influenza virus afflicts millions of people worldwide on an annual basis. There is an ever-present risk that animal viruses will cross the species barrier to cause epidemics and pandemics resulting in great morbidity and mortality. Zoonosis outbreaks, such as the H7N9 outbreak, underscore the need to better understand the molecular organization of viral immunogens, such as recombinant influenza virus hemagglutinin (HA) proteins, used in influenza virus subunit vaccines in order to optimize vaccine efficacy. Here, using cryo-electron microscopy and image analysis, we show that recombinant H7 HA in vaccines formed macromolecular complexes consisting of variable numbers of HA subunits (range, 6 to 8). In addition, HA complexes were distributed across at least four distinct structural classes (polymorphisms). Three-dimensional (3D) reconstruction and molecular modeling indicated that HA was in the prefusion state and suggested that the oligomerization and the structural polymorphisms observed were due to hydrophobic interactions involving the transmembrane regions. These experiments suggest that characterization of the molecular structures of influenza virus HA complexes used in subunit vaccines will lead to better understanding of the differences in vaccine efficacy and to the optimization of subunit vaccines to prevent influenza virus infection.

http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

Clinical and Vaccine Immunology American Society For Microbiology

http://www.deepdyve.com/lp/american-society-for-microbiology/characterization-of-influenza-vaccine-hemagglutinin-complexes-by-cryo-x75Tei0Djr

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms

McCraw, Dustin M.; Gallagher, John R.; Harris, Audray K.

Clinical and Vaccine Immunology , Volume 23 (6) – Jun 1, 2016

Abstract

References (123)

Cuiling Xu, F. Havers, Lijie Wang, Tao Chen, Jing-hong Shi, Dayan Wang, Jing Yang, Lei Yang, Marc-Alain Widdowson, Y. Shu (2013)

Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, China

Emerging Infectious Diseases, 19

(GrossPA, EnnisFA 1977 Influenza vaccine: split-product versus whole-virus types—how do they differ? N Engl J Med 296:567–568. doi:10.1056/NEJM197703102961012.836542)

GrossPA, EnnisFA 1977 Influenza vaccine: split-product versus whole-virus types—how do they differ? N Engl J Med 296:567–568. doi:10.1056/NEJM197703102961012.836542

GrossPA, EnnisFA 1977 Influenza vaccine: split-product versus whole-virus types—how do they differ? N Engl J Med 296:567–568. doi:10.1056/NEJM197703102961012.836542, GrossPA, EnnisFA 1977 Influenza vaccine: split-product versus whole-virus types—how do they differ? N Engl J Med 296:567–568. doi:10.1056/NEJM197703102961012.836542

(KrammerF, AlbrechtRA, TanGS, MargineI, HaiR, SchmolkeM, RunstadlerJ, AndrewsSF, WilsonPC, CoxRJ, TreanorJJ, Garcia-SastreA, PaleseP 2014 Divergent H7 immunogens offer protection from H7N9 virus challenge. J Virol 88:3976–3985. doi:10.1128/JVI.03095-13.24453375)

KrammerF, AlbrechtRA, TanGS, MargineI, HaiR, SchmolkeM, RunstadlerJ, AndrewsSF, WilsonPC, CoxRJ, TreanorJJ, Garcia-SastreA, PaleseP 2014 Divergent H7 immunogens offer protection from H7N9 virus challenge. J Virol 88:3976–3985. doi:10.1128/JVI.03095-13.24453375, KrammerF, AlbrechtRA, TanGS, MargineI, HaiR, SchmolkeM, RunstadlerJ, AndrewsSF, WilsonPC, CoxRJ, TreanorJJ, Garcia-SastreA, PaleseP 2014 Divergent H7 immunogens offer protection from H7N9 virus challenge. J Virol 88:3976–3985. doi:10.1128/JVI.03095-13.24453375

(GlennGM, SmithG, FriesL, RaghunandanR, LuH, ZhouB, ThomasDN, HickmanSP, KpameganE, BoddapatiS, PiedraPA 2013 Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine 31:524–532. doi:10.1016/j.vaccine.2012.11.009.23153449)

GlennGM, SmithG, FriesL, RaghunandanR, LuH, ZhouB, ThomasDN, HickmanSP, KpameganE, BoddapatiS, PiedraPA 2013 Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine 31:524–532. doi:10.1016/j.vaccine.2012.11.009.23153449, GlennGM, SmithG, FriesL, RaghunandanR, LuH, ZhouB, ThomasDN, HickmanSP, KpameganE, BoddapatiS, PiedraPA 2013 Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine 31:524–532. doi:10.1016/j.vaccine.2012.11.009.23153449

Chia-Ying Wu, Ching-Yuan Chang, Hsiu-Hua Ma, Chiung-Wen Wang, Yung-Tsung Chen, P. Hsiao, Ching-Chuan Chang, Chi-Hsien Chan, Chung‐Cheng Liu, Juine-Ruey Chen (2014)

Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses.

Vaccine, 32 35

Qinjian Zhao, C. Potter, B. Carragher, G. Lander, Jaime Sworen, Victoria Towne, Dicky Abraham, P. Duncan, M. Washabaugh, R. Sitrin (2014)

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy

Human Vaccines & Immunotherapeutics, 10

Gavin Smith, J. Bahl, J. Bahl, D. Vijaykrishna, D. Vijaykrishna, Jinxia Zhang, Jinxia Zhang, L. Poon, Honglin Chen, Honglin Chen, R. Webster, J. Peiris, Y. Guan, Y. Guan (2009)

Dating the emergence of pandemic influenza viruses

Proceedings of the National Academy of Sciences, 106

I. Wilson, J. Skehel, D. Wiley (1981)

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

Nature, 289

(SkehelJJ, BayleyPM, BrownEB, MartinSR, WaterfieldMD, WhiteJM, WilsonIA, WileyDC 1982 Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A 79:968–972. doi:10.1073/pnas.79.4.968.6951181)

SkehelJJ, BayleyPM, BrownEB, MartinSR, WaterfieldMD, WhiteJM, WilsonIA, WileyDC 1982 Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A 79:968–972. doi:10.1073/pnas.79.4.968.6951181, SkehelJJ, BayleyPM, BrownEB, MartinSR, WaterfieldMD, WhiteJM, WilsonIA, WileyDC 1982 Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A 79:968–972. doi:10.1073/pnas.79.4.968.6951181

R. Daniels, A. Douglas, J. Skehel, D. Wiley (1983)

Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.

The Journal of general virology, 64 (Pt 8)

(HeymannJB, BelnapDM 2007 Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol 157:3–18. doi:10.1016/j.jsb.2006.06.006.17011211)

HeymannJB, BelnapDM 2007 Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol 157:3–18. doi:10.1016/j.jsb.2006.06.006.17011211

HeymannJB, BelnapDM 2007 Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol 157:3–18. doi:10.1016/j.jsb.2006.06.006.17011211, HeymannJB, BelnapDM 2007 Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol 157:3–18. doi:10.1016/j.jsb.2006.06.006.17011211

P. Bullough, F. Hughson, J. Skehel, D. Wiley (1994)

Structure of influenza haemagglutinin at the pH of membrane fusion

Nature, 371

(XiongX, MartinSR, HaireLF, WhartonSA, DanielsRS, BennettMS, McCauleyJW, CollinsPJ, WalkerPA, SkehelJJ, GamblinSJ 2013 Receptor binding by an H7N9 influenza virus from humans. Nature 499:496–499. doi:10.1038/nature12372.23787694)

XiongX, MartinSR, HaireLF, WhartonSA, DanielsRS, BennettMS, McCauleyJW, CollinsPJ, WalkerPA, SkehelJJ, GamblinSJ 2013 Receptor binding by an H7N9 influenza virus from humans. Nature 499:496–499. doi:10.1038/nature12372.23787694, XiongX, MartinSR, HaireLF, WhartonSA, DanielsRS, BennettMS, McCauleyJW, CollinsPJ, WalkerPA, SkehelJJ, GamblinSJ 2013 Receptor binding by an H7N9 influenza virus from humans. Nature 499:496–499. doi:10.1038/nature12372.23787694

(MangoldCM, UnckellF, WerrM, StreeckRE 1995 Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535–543. doi:10.1006/viro.1995.1435.7645257)

MangoldCM, UnckellF, WerrM, StreeckRE 1995 Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535–543. doi:10.1006/viro.1995.1435.7645257, MangoldCM, UnckellF, WerrM, StreeckRE 1995 Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535–543. doi:10.1006/viro.1995.1435.7645257

R. Webster, W. Laver (1966)

Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus.

Journal of immunology, 96 4

(McAleerWJ, BuynakEB, MaigetterRZ, WamplerDE, MillerWJ, HillemanMR 1984 Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180. doi:10.1038/307178a0.6318124)

McAleerWJ, BuynakEB, MaigetterRZ, WamplerDE, MillerWJ, HillemanMR 1984 Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180. doi:10.1038/307178a0.6318124

McAleerWJ, BuynakEB, MaigetterRZ, WamplerDE, MillerWJ, HillemanMR 1984 Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180. doi:10.1038/307178a0.6318124, McAleerWJ, BuynakEB, MaigetterRZ, WamplerDE, MillerWJ, HillemanMR 1984 Human hepatitis B vaccine from recombinant yeast. Nature 307:178–180. doi:10.1038/307178a0.6318124

(HarrisAK, MeyersonJR, MatsuokaY, KuybedaO, MoranA, BlissD, DasSR, YewdellJW, SapiroG, SubbaraoK, SubramaniamS 2013 Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A 110:4592–4597. doi:10.1073/pnas.1214913110.23460696)

HarrisAK, MeyersonJR, MatsuokaY, KuybedaO, MoranA, BlissD, DasSR, YewdellJW, SapiroG, SubbaraoK, SubramaniamS 2013 Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A 110:4592–4597. doi:10.1073/pnas.1214913110.23460696, HarrisAK, MeyersonJR, MatsuokaY, KuybedaO, MoranA, BlissD, DasSR, YewdellJW, SapiroG, SubbaraoK, SubramaniamS 2013 Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A 110:4592–4597. doi:10.1073/pnas.1214913110.23460696

T. Lam, Boping Zhou, Jia Wang, Yujuan Chai, Yongyi Shen, Xinchun Chen, Chi Ma, W. Hong, Yin Chen, Yanjun Zhang, L. Duan, Pei‐Jer Chen, Junfei Jiang, Yu Zhang, Lifeng Li, L. Poon, R. Webby, David Smith, G. Leung, J. Peiris, E. Holmes, Y. Guan, Huachen Zhu (2015)

Dissemination, divergence and establishment of H7N9 influenza viruses in China

Nature, 522

(KanekiyoM, WeiCJ, YassineHM, McTamneyPM, BoyingtonJC, WhittleJR, RaoSS, KongWP, WangL, NabelGJ 2013 Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499:102–106. doi:10.1038/nature12202.23698367)

KanekiyoM, WeiCJ, YassineHM, McTamneyPM, BoyingtonJC, WhittleJR, RaoSS, KongWP, WangL, NabelGJ 2013 Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499:102–106. doi:10.1038/nature12202.23698367, KanekiyoM, WeiCJ, YassineHM, McTamneyPM, BoyingtonJC, WhittleJR, RaoSS, KongWP, WangL, NabelGJ 2013 Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499:102–106. doi:10.1038/nature12202.23698367

H. Jin, K. Subbarao (2020)

Live attenuated influenza vaccine.

Current topics in microbiology and immunology, 386

H. Yassine, J. Boyington, P. McTamney, Chih-Jen Wei, M. Kanekiyo, W. Kong, J. Gallagher, Lingshu Wang, Yi Zhang, M. Joyce, D. Lingwood, Syed Moin, H. Andersen, Y. Okuno, Srinivas Rao, Audray Harris, P. Kwong, J. Mascola, G. Nabel, B. Graham (2015)

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

Nature Medicine, 21

Guang Tang, L. Peng, P. Baldwin, D. Mann, Wen Jiang, I. Rees, S. Ludtke (2007)

EMAN2: an extensible image processing suite for electron microscopy.

Journal of structural biology, 157 1

E. Me (2013)

MANUFACTURING PROCESS-I

(TreanorJJ, El SahlyH, KingJ, GrahamI, IziksonR, KohbergerR, PatriarcaP, CoxM 2011 Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine 29:7733–7739. doi:10.1016/j.vaccine.2011.07.128.21835220)

TreanorJJ, El SahlyH, KingJ, GrahamI, IziksonR, KohbergerR, PatriarcaP, CoxM 2011 Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine 29:7733–7739. doi:10.1016/j.vaccine.2011.07.128.21835220, TreanorJJ, El SahlyH, KingJ, GrahamI, IziksonR, KohbergerR, PatriarcaP, CoxM 2011 Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine 29:7733–7739. doi:10.1016/j.vaccine.2011.07.128.21835220

(BucklandB, BoulangerR, FinoM, SrivastavaI, HoltzK, KhramtsovN, McPhersonC, MeghrousJ, KuberaP, CoxMM 2014 Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. Vaccine 32:5496–5502. doi:10.1016/j.vaccine.2014.07.074.25131727)

BucklandB, BoulangerR, FinoM, SrivastavaI, HoltzK, KhramtsovN, McPhersonC, MeghrousJ, KuberaP, CoxMM 2014 Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. Vaccine 32:5496–5502. doi:10.1016/j.vaccine.2014.07.074.25131727, BucklandB, BoulangerR, FinoM, SrivastavaI, HoltzK, KhramtsovN, McPhersonC, MeghrousJ, KuberaP, CoxMM 2014 Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. Vaccine 32:5496–5502. doi:10.1016/j.vaccine.2014.07.074.25131727

(ZhaoQ, PotterCS, CarragherB, LanderG, SworenJ, TowneV, AbrahamD, DuncanP, WashabaughMW, SitrinRD 2014 Characterization of virus-like particles in GARDASIL by cryo transmission electron microscopy. Hum Vaccin Immunother 10:734–739. doi:10.4161/hv.27316.24299977)

ZhaoQ, PotterCS, CarragherB, LanderG, SworenJ, TowneV, AbrahamD, DuncanP, WashabaughMW, SitrinRD 2014 Characterization of virus-like particles in GARDASIL by cryo transmission electron microscopy. Hum Vaccin Immunother 10:734–739. doi:10.4161/hv.27316.24299977, ZhaoQ, PotterCS, CarragherB, LanderG, SworenJ, TowneV, AbrahamD, DuncanP, WashabaughMW, SitrinRD 2014 Characterization of virus-like particles in GARDASIL by cryo transmission electron microscopy. Hum Vaccin Immunother 10:734–739. doi:10.4161/hv.27316.24299977

Jue Chen, Kon-Ho Lee, D. Steinhauer, D. Stevens, J. Skehel, D. Wiley (1998)

Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation

Cell, 95

J. Heymann, D. Belnap, D. Belnap (2007)

Bsoft: image processing and molecular modeling for electron microscopy.

Journal of structural biology, 157 1

Yi Shi, Wei Zhang, Fei Wang, J. Qi, Ying Wu, Hao Song, F. Gao, Y. Bi, Yanfang Zhang, Z. Fan, C. Qin, Honglei Sun, Jinhua Liu, J. Haywood, Wenjun Liu, W. Gong, Dayan Wang, Y. Shu, Yu Wang, Jinghua Yan, G. Gao (2013)

Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses

Science, 342

R. Webster, L. Brown, D. Jackson (1983)

Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.

Virology, 126 2

(PettersenEF, GoddardTD, HuangCC, CouchGS, GreenblattDM, MengEC, FerrinTE 2004 UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084.15264254)

PettersenEF, GoddardTD, HuangCC, CouchGS, GreenblattDM, MengEC, FerrinTE 2004 UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084.15264254, PettersenEF, GoddardTD, HuangCC, CouchGS, GreenblattDM, MengEC, FerrinTE 2004 UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084.15264254

J. Aguilar-Yañez, Roberto Portillo-Lara, Gonzalo Mendoza-Ochoa, S. García-Echauri, F. López-Pacheco, David Bulnes‐Abundis, Johari Salgado-Gallegos, I. Lara-Mayorga, Yenny Webb-Vargas, Felipe León-Angel, Ramón Rivero-Aranda, Y. Oropeza-Almazán, G. Ruiz-Palacios, Manuel Zertuche-Guerra, R. DuBois, S. White, S. Schultz‐Cherry, C. Russell, M. Álvarez (2010)

An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli

PLoS ONE, 5

X. Xiong, S. Martin, L. Haire, S. Wharton, R. Daniels, M. Bennett, J. McCauley, P. Collins, P. Walker, J. Skehel, S. Gamblin (2013)

Receptor binding by an H7N9 influenza virus from humans

Nature, 499

J. Treanor, H. Sahly, J. King, Irene Graham, R. Izikson, R. Kohberger, P. Patriarca, M. Cox (2011)

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Vaccine, 29 44

G. Glenn, Gale Smith, L. Fries, R. Raghunandan, Hanxin Lu, Bin Zhou, D. Thomas, S. Hickman, Eloi Kpamegan, S. Boddapati, P. Piedra (2013)

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.

Vaccine, 31 3

C. Mangold, F. Unckell, M. Werr, R. Streeck (1995)

Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region.

Virology, 211 2

(LünsdorfH, GurramkondaC, AdnanA, KhannaN, RinasU 2011 Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microb Cell Fact 10:48. doi:10.1186/1475-2859-10-48.21703024)

LünsdorfH, GurramkondaC, AdnanA, KhannaN, RinasU 2011 Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microb Cell Fact 10:48. doi:10.1186/1475-2859-10-48.21703024, LünsdorfH, GurramkondaC, AdnanA, KhannaN, RinasU 2011 Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microb Cell Fact 10:48. doi:10.1186/1475-2859-10-48.21703024

(SobhanieM, MatsuokaY, JegaskandaS, FitzgeraldT, MalloryR, ChenZ, LukeC, TreanorJ, SubbaraoK 9 12 2015 Evaluation of the safety and immunogenicity of a candidate pandemic live attenuated influenza vaccine (pLAIV) against influenza A(H7N9). J Infect Dis doi:10.1093/infdis/jiv526.)

SobhanieM, MatsuokaY, JegaskandaS, FitzgeraldT, MalloryR, ChenZ, LukeC, TreanorJ, SubbaraoK 9 12 2015 Evaluation of the safety and immunogenicity of a candidate pandemic live attenuated influenza vaccine (pLAIV) against influenza A(H7N9). J Infect Dis doi:10.1093/infdis/jiv526., SobhanieM, MatsuokaY, JegaskandaS, FitzgeraldT, MalloryR, ChenZ, LukeC, TreanorJ, SubbaraoK 9 12 2015 Evaluation of the safety and immunogenicity of a candidate pandemic live attenuated influenza vaccine (pLAIV) against influenza A(H7N9). J Infect Dis doi:10.1093/infdis/jiv526.

(JinH, SubbaraoK 2015 Live attenuated influenza vaccine. Curr Top Microbiol Immunol 386:181–204. doi:10.1007/82_2014_410.25059893)

JinH, SubbaraoK 2015 Live attenuated influenza vaccine. Curr Top Microbiol Immunol 386:181–204. doi:10.1007/82_2014_410.25059893

JinH, SubbaraoK 2015 Live attenuated influenza vaccine. Curr Top Microbiol Immunol 386:181–204. doi:10.1007/82_2014_410.25059893, JinH, SubbaraoK 2015 Live attenuated influenza vaccine. Curr Top Microbiol Immunol 386:181–204. doi:10.1007/82_2014_410.25059893

(XuR, EkiertDC, KrauseJC, HaiR, CroweJEJr, WilsonIA 2010 Structural basis of preexisting immunity to the H1N1 pandemic influenza virus. Science 328:357–360. doi:10.1126/science.1186430.20339031)

XuR, EkiertDC, KrauseJC, HaiR, CroweJEJr, WilsonIA 2010 Structural basis of preexisting immunity to the H1N1 pandemic influenza virus. Science 328:357–360. doi:10.1126/science.1186430.20339031

XuR, EkiertDC, KrauseJC, HaiR, CroweJEJr, WilsonIA 2010 Structural basis of preexisting immunity to the H1N1 pandemic influenza virus. Science 328:357–360. doi:10.1126/science.1186430.20339031, XuR, EkiertDC, KrauseJC, HaiR, CroweJEJr, WilsonIA 2010 Structural basis of preexisting immunity to the H1N1 pandemic influenza virus. Science 328:357–360. doi:10.1126/science.1186430.20339031

(WhiteJ, HeleniusA, GethingMJ 1982 Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 300:658–659. doi:10.1038/300658a0.6815542)

WhiteJ, HeleniusA, GethingMJ 1982 Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 300:658–659. doi:10.1038/300658a0.6815542

WhiteJ, HeleniusA, GethingMJ 1982 Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 300:658–659. doi:10.1038/300658a0.6815542, WhiteJ, HeleniusA, GethingMJ 1982 Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 300:658–659. doi:10.1038/300658a0.6815542

(SegalMS, ByeJM, SambrookJF, GethingMJ 1992 Disulfide bond formation during the folding of influenza virus hemagglutinin. J Cell Biol 118:227–244. doi:10.1083/jcb.118.2.227.1321156)

SegalMS, ByeJM, SambrookJF, GethingMJ 1992 Disulfide bond formation during the folding of influenza virus hemagglutinin. J Cell Biol 118:227–244. doi:10.1083/jcb.118.2.227.1321156

SegalMS, ByeJM, SambrookJF, GethingMJ 1992 Disulfide bond formation during the folding of influenza virus hemagglutinin. J Cell Biol 118:227–244. doi:10.1083/jcb.118.2.227.1321156, SegalMS, ByeJM, SambrookJF, GethingMJ 1992 Disulfide bond formation during the folding of influenza virus hemagglutinin. J Cell Biol 118:227–244. doi:10.1083/jcb.118.2.227.1321156

S. Scheres (2012)

RELION: Implementation of a Bayesian approach to cryo-EM structure determination

Journal of Structural Biology, 180

Audray Harris, J. Meyerson, Y. Matsuoka, O. Kuybeda, A. Moran, D. Bliss, Suman Das, J. Yewdell, G. Sapiro, K. Subbarao, S. Subramaniam (2013)

Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies

Proceedings of the National Academy of Sciences, 110

Joan Ngwuta, Man Chen, K. Modjarrad, K. Modjarrad, M. Joyce, M. Kanekiyo, Azad Kumar, H. Yassine, Syed Moin, A. Killikelly, G. Chuang, A. Druz, I. Georgiev, E. Rundlet, M. Sastry, G. Stewart-Jones, Yongping Yang, Baoshan Zhang, M. Nason, Cristina Capella, M. Peeples, J. Ledgerwood, Jason McLellan, Jason McLellan, P. Kwong, B. Graham (2015)

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

Science Translational Medicine, 7

Mark Segal, Jacqueline Bye, Joseph Sambrook, M. Gething (1992)

Disulfide bond formation during the folding of influenza virus hemagglutinin

The Journal of Cell Biology, 118

F. Krammer, R. Albrecht, G. Tan, Irina Margine, R. Hai, M. Schmolke, J. Runstadler, Sarah Andrews, P. Wilson, R. Cox, J. Treanor, A. García-Sastre, P. Palese (2014)

Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge

Journal of Virology, 88

S. Fuller, J. Berriman, S. Butcher, B. Gowen (1995)

Low pH induces swiveling of the glycoprotein heterodimers in the Semliki forest virus spike complex

Cell, 81

M. Cox, P. Patriarca, J. Treanor (2008)

FluBlok, a recombinant hemagglutinin influenza vaccine

Influenza and Other Respiratory Viruses, 2

(XuR, de VriesRP, ZhuX, NycholatCM, McBrideR, YuW, PaulsonJC, WilsonIA 2013 Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science 342:1230–1235. doi:10.1126/science.1243761.24311689)

XuR, de VriesRP, ZhuX, NycholatCM, McBrideR, YuW, PaulsonJC, WilsonIA 2013 Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science 342:1230–1235. doi:10.1126/science.1243761.24311689, XuR, de VriesRP, ZhuX, NycholatCM, McBrideR, YuW, PaulsonJC, WilsonIA 2013 Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science 342:1230–1235. doi:10.1126/science.1243761.24311689

(RhodesDG, HoltzK, RobinsonP, WangK, McPhersonCE, CoxMM, SrivastavaIK 2015 Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate. Vaccine 33:6011–6016. doi:10.1016/j.vaccine.2015.09.029.26409814)

RhodesDG, HoltzK, RobinsonP, WangK, McPhersonCE, CoxMM, SrivastavaIK 2015 Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate. Vaccine 33:6011–6016. doi:10.1016/j.vaccine.2015.09.029.26409814, RhodesDG, HoltzK, RobinsonP, WangK, McPhersonCE, CoxMM, SrivastavaIK 2015 Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate. Vaccine 33:6011–6016. doi:10.1016/j.vaccine.2015.09.029.26409814

(JacksonLA, CampbellJD, FreySE, EdwardsKM, KeitelWA, KotloffKL, BerryAA, GrahamI, AtmarRL, CreechCB, ThomsenIP, PatelSM, GutierrezAF, AndersonEL, El SahlyHM, HillH, NoahDL, BellamyAR 2015 Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial. JAMA 314:237–246. doi:10.1001/jama.2015.7916.26197184)

JacksonLA, CampbellJD, FreySE, EdwardsKM, KeitelWA, KotloffKL, BerryAA, GrahamI, AtmarRL, CreechCB, ThomsenIP, PatelSM, GutierrezAF, AndersonEL, El SahlyHM, HillH, NoahDL, BellamyAR 2015 Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial. JAMA 314:237–246. doi:10.1001/jama.2015.7916.26197184, JacksonLA, CampbellJD, FreySE, EdwardsKM, KeitelWA, KotloffKL, BerryAA, GrahamI, AtmarRL, CreechCB, ThomsenIP, PatelSM, GutierrezAF, AndersonEL, El SahlyHM, HillH, NoahDL, BellamyAR 2015 Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial. JAMA 314:237–246. doi:10.1001/jama.2015.7916.26197184

R. Xu, R. Vries, Xueyong Zhu, Corwin Nycholat, Ryan McBride, Wenli Yu, J. Paulson, I. Wilson (2013)

Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses

Science, 342

(CoxMM, PatriarcaPA, TreanorJ 2008 FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir Viruses 2:211–219. doi:10.1111/j.1750-2659.2008.00053.x.19453397)

CoxMM, PatriarcaPA, TreanorJ 2008 FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir Viruses 2:211–219. doi:10.1111/j.1750-2659.2008.00053.x.19453397

CoxMM, PatriarcaPA, TreanorJ 2008 FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir Viruses 2:211–219. doi:10.1111/j.1750-2659.2008.00053.x.19453397, CoxMM, PatriarcaPA, TreanorJ 2008 FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir Viruses 2:211–219. doi:10.1111/j.1750-2659.2008.00053.x.19453397

(2014)

Squalene - adjuvanted H 7 N 9 virus

J. McLellan, Man Chen, Sherman Leung, Kevin Graepel, Xiulian Du, Yongping Yang, T. Zhou, U. Baxa, E. Yasuda, T. Beaumont, Azad Kumar, K. Modjarrad, Z. Zheng, Min Zhao, N. Xia, P. Kwong, B. Graham (2013)

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Science, 340

M. Gething, J. Bye, J. Skehel, M. Waterfield (1980)

Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus

Nature, 287

(WatanabeT, KisoM, FukuyamaS, NakajimaN, ImaiM, YamadaS, MurakamiS, YamayoshiS, Iwatsuki-HorimotoK, SakodaY, TakashitaE, McBrideR, NodaT, HattaM, ImaiH, ZhaoD, KishidaN, ShirakuraM, de VriesRP, ShichinoheS, OkamatsuM, TamuraT, TomitaY, FujimotoN, GotoK, KatsuraH, KawakamiE, IshikawaI, WatanabeS, ItoM, Sakai-TagawaY, SugitaY, UrakiR, YamajiR, EisfeldAJ, ZhongG, FanS, PingJ, MaherEA, HansonA, UchidaY, SaitoT, OzawaM, NeumannG, KidaH, OdagiriT, PaulsonJC, HasegawaH, TashiroM, KawaokaY 2013 Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551–555. doi:10.1038/nature12392.23842494)

WatanabeT, KisoM, FukuyamaS, NakajimaN, ImaiM, YamadaS, MurakamiS, YamayoshiS, Iwatsuki-HorimotoK, SakodaY, TakashitaE, McBrideR, NodaT, HattaM, ImaiH, ZhaoD, KishidaN, ShirakuraM, de VriesRP, ShichinoheS, OkamatsuM, TamuraT, TomitaY, FujimotoN, GotoK, KatsuraH, KawakamiE, IshikawaI, WatanabeS, ItoM, Sakai-TagawaY, SugitaY, UrakiR, YamajiR, EisfeldAJ, ZhongG, FanS, PingJ, MaherEA, HansonA, UchidaY, SaitoT, OzawaM, NeumannG, KidaH, OdagiriT, PaulsonJC, HasegawaH, TashiroM, KawaokaY 2013 Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551–555. doi:10.1038/nature12392.23842494, WatanabeT, KisoM, FukuyamaS, NakajimaN, ImaiM, YamadaS, MurakamiS, YamayoshiS, Iwatsuki-HorimotoK, SakodaY, TakashitaE, McBrideR, NodaT, HattaM, ImaiH, ZhaoD, KishidaN, ShirakuraM, de VriesRP, ShichinoheS, OkamatsuM, TamuraT, TomitaY, FujimotoN, GotoK, KatsuraH, KawakamiE, IshikawaI, WatanabeS, ItoM, Sakai-TagawaY, SugitaY, UrakiR, YamajiR, EisfeldAJ, ZhongG, FanS, PingJ, MaherEA, HansonA, UchidaY, SaitoT, OzawaM, NeumannG, KidaH, OdagiriT, PaulsonJC, HasegawaH, TashiroM, KawaokaY 2013 Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551–555. doi:10.1038/nature12392.23842494

(LeePS, WilsonIA 2015 Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol 386:323–341. doi:10.1007/82_2014_413.25037260)

LeePS, WilsonIA 2015 Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol 386:323–341. doi:10.1007/82_2014_413.25037260

LeePS, WilsonIA 2015 Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol 386:323–341. doi:10.1007/82_2014_413.25037260, LeePS, WilsonIA 2015 Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol 386:323–341. doi:10.1007/82_2014_413.25037260

Qiliang Liu, Kang Liu, C. Xue, Jianqiang Zhou, Xiaoming Li, Dongyu Luo, Jing Zheng, Shun Xu, George Liu, Yongchang Cao (2014)

Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice

Vaccine, 32

(ChenJ, LeeKH, SteinhauerDA, StevensDJ, SkehelJJ, WileyDC 1998 Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409–417. doi:10.1016/S0092-8674(00)81771-7.9814710)

ChenJ, LeeKH, SteinhauerDA, StevensDJ, SkehelJJ, WileyDC 1998 Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409–417. doi:10.1016/S0092-8674(00)81771-7.9814710, ChenJ, LeeKH, SteinhauerDA, StevensDJ, SkehelJJ, WileyDC 1998 Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409–417. doi:10.1016/S0092-8674(00)81771-7.9814710

E. Scolnick, A. Mclean, D. West, W. Mcaleer, W. Miller, E. Buynak (1984)

Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.

JAMA, 251 21

R. Garten, C. Davis, C. Russell, B. Shu, S. Lindstrom, A. Balish, W. Sessions, Xiyan Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, Catherine Smith, S. Emery, M. Hillman, P. Rivailler, James Smagala, M. Graaf, D. Burke, R. Fouchier, C. Pappas, C. Alpuche-Aranda, H. Lopez-Gatell, Hiram Olivera, Irma López, Christopher Myers, D. Faix, P. Blair, Cindy Yu, Kimberly Keene, P. Dotson, D. Boxrud, A. Sambol, S. Abid, K. George, T. Bannerman, A. Moore, D. Stringer, Patricia Blevins, Gail Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. Guevara, E. Belongia, P. Clark, S. Beatrice, R. Donis, J. Katz, L. Finelli, C. Bridges, M. Shaw, D. Jernigan, T. Uyeki, Derek Smith, A. Klimov, N. Cox (2009)

Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

Science, 325

(2016)

23 Number 6 cvi.asm.org 495 Clinical and Vaccine Immunology

(LaverWG, GerhardW, WebsterRG, FrankelME, AirGM 1979 Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies. Proc Natl Acad Sci U S A 76:1425–1429. doi:10.1073/pnas.76.3.1425.86990)

LaverWG, GerhardW, WebsterRG, FrankelME, AirGM 1979 Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies. Proc Natl Acad Sci U S A 76:1425–1429. doi:10.1073/pnas.76.3.1425.86990, LaverWG, GerhardW, WebsterRG, FrankelME, AirGM 1979 Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies. Proc Natl Acad Sci U S A 76:1425–1429. doi:10.1073/pnas.76.3.1425.86990

(LiuQ, LiuK, XueC, ZhouJ, LiX, LuoD, ZhengJ, XuS, LiuGD, CaoY 2014 Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice. Vaccine 32:3041–3049. doi:10.1016/j.vaccine.2014.03.058.24704333)

LiuQ, LiuK, XueC, ZhouJ, LiX, LuoD, ZhengJ, XuS, LiuGD, CaoY 2014 Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice. Vaccine 32:3041–3049. doi:10.1016/j.vaccine.2014.03.058.24704333, LiuQ, LiuK, XueC, ZhouJ, LiX, LuoD, ZhengJ, XuS, LiuGD, CaoY 2014 Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice. Vaccine 32:3041–3049. doi:10.1016/j.vaccine.2014.03.058.24704333

(SheYM, ChengK, FarnsworthA, LiX, CyrTD 2013 Surface modifications of influenza proteins upon virus inactivation by β-propiolactone. Proteomics 13:3537–3547. doi:10.1002/pmic.201300096.24123778)

SheYM, ChengK, FarnsworthA, LiX, CyrTD 2013 Surface modifications of influenza proteins upon virus inactivation by β-propiolactone. Proteomics 13:3537–3547. doi:10.1002/pmic.201300096.24123778

SheYM, ChengK, FarnsworthA, LiX, CyrTD 2013 Surface modifications of influenza proteins upon virus inactivation by β-propiolactone. Proteomics 13:3537–3547. doi:10.1002/pmic.201300096.24123778, SheYM, ChengK, FarnsworthA, LiX, CyrTD 2013 Surface modifications of influenza proteins upon virus inactivation by β-propiolactone. Proteomics 13:3537–3547. doi:10.1002/pmic.201300096.24123778

Audray Harris, G. Cardone, Dennis Winkler, J. Heymann, M. Brecher, J. White, A. Steven (2006)

Influenza virus pleiomorphy characterized by cryoelectron tomography

Proceedings of the National Academy of Sciences, 103

D. Ekiert, R. Friesen, G. Bhabha, Ted Kwaks, M. Jongeneelen, Wenli Yu, C. Ophorst, F. Cox, Hans Korse, Boerries Brandenburg, R. Vogels, J. Brakenhoff, R. Kompier, Martin Koldijk, L. Cornelissen, L. Poon, M. Peiris, W. Koudstaal, I. Wilson, J. Goudsmit (2011)

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Science, 333

Lassi Liljeroos, M. Krzyzaniak, A. Helenius, S. Butcher (2013)

Architecture of respiratory syncytial virus revealed by electron cryotomography

Proceedings of the National Academy of Sciences, 110

P. Pushko, L. Pujanauski, Xiangjie Sun, Melissa Pearce, R. Hidajat, Thomas Kort, L. Schwartzman, I. Tretyakova, Liu Chunqing, J. Taubenberger, T. Tumpey (2015)

Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Vaccine, 33 38

(LaverWG, ValentineRC 1969 Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38:105–119. doi:10.1016/0042-6822(69)90132-9.5784043)

LaverWG, ValentineRC 1969 Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38:105–119. doi:10.1016/0042-6822(69)90132-9.5784043

LaverWG, ValentineRC 1969 Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38:105–119. doi:10.1016/0042-6822(69)90132-9.5784043, LaverWG, ValentineRC 1969 Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38:105–119. doi:10.1016/0042-6822(69)90132-9.5784043

(EkiertDC, FriesenRH, BhabhaG, KwaksT, JongeneelenM, YuW, OphorstC, CoxF, KorseHJ, BrandenburgB, VogelsR, BrakenhoffJP, KompierR, KoldijkMH, CornelissenLA, PoonLL, PeirisM, KoudstaalW, WilsonIA, GoudsmitJ 2011 A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850. doi:10.1126/science.1204839.21737702)

EkiertDC, FriesenRH, BhabhaG, KwaksT, JongeneelenM, YuW, OphorstC, CoxF, KorseHJ, BrandenburgB, VogelsR, BrakenhoffJP, KompierR, KoldijkMH, CornelissenLA, PoonLL, PeirisM, KoudstaalW, WilsonIA, GoudsmitJ 2011 A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850. doi:10.1126/science.1204839.21737702, EkiertDC, FriesenRH, BhabhaG, KwaksT, JongeneelenM, YuW, OphorstC, CoxF, KorseHJ, BrandenburgB, VogelsR, BrakenhoffJP, KompierR, KoldijkMH, CornelissenLA, PoonLL, PeirisM, KoudstaalW, WilsonIA, GoudsmitJ 2011 A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843–850. doi:10.1126/science.1204839.21737702

D. Rhodes, Kathy Holtz, P. Robinson, Keyang Wang, Clifton McPherson, M. Cox, I. Srivastava (2015)

Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate.

Vaccine, 33 44

Judy White, A. Helenius, M. Gething (1982)

Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion

Nature, 300

D. Lowy (2016)

HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.

The Journal of clinical investigation, 126 1

(RussellRJ, GamblinSJ, HaireLF, StevensDJ, XiaoB, HaY, SkehelJJ 2004 H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287–296. doi:10.1016/j.virol.2004.04.040.15246268)

RussellRJ, GamblinSJ, HaireLF, StevensDJ, XiaoB, HaY, SkehelJJ 2004 H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287–296. doi:10.1016/j.virol.2004.04.040.15246268, RussellRJ, GamblinSJ, HaireLF, StevensDJ, XiaoB, HaY, SkehelJJ 2004 H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287–296. doi:10.1016/j.virol.2004.04.040.15246268

(DanielsRS, DouglasAR, SkehelJJ, WileyDC 1983 Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol 64(Part 8):1657–1662. doi:10.1099/0022-1317-64-8-1657.6192202)

DanielsRS, DouglasAR, SkehelJJ, WileyDC 1983 Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol 64(Part 8):1657–1662. doi:10.1099/0022-1317-64-8-1657.6192202, DanielsRS, DouglasAR, SkehelJJ, WileyDC 1983 Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol 64(Part 8):1657–1662. doi:10.1099/0022-1317-64-8-1657.6192202

(YassineHM, BoyingtonJC, McTamneyPM, WeiCJ, KanekiyoM, KongWP, GallagherJR, WangL, ZhangY, JoyceMG, LingwoodD, MoinSM, AndersenH, OkunoY, RaoSS, HarrisAK, KwongPD, MascolaJR, NabelGJ, GrahamBS 2015 Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med 21:1065–1070. doi:10.1038/nm.3927.26301691)

YassineHM, BoyingtonJC, McTamneyPM, WeiCJ, KanekiyoM, KongWP, GallagherJR, WangL, ZhangY, JoyceMG, LingwoodD, MoinSM, AndersenH, OkunoY, RaoSS, HarrisAK, KwongPD, MascolaJR, NabelGJ, GrahamBS 2015 Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med 21:1065–1070. doi:10.1038/nm.3927.26301691, YassineHM, BoyingtonJC, McTamneyPM, WeiCJ, KanekiyoM, KongWP, GallagherJR, WangL, ZhangY, JoyceMG, LingwoodD, MoinSM, AndersenH, OkunoY, RaoSS, HarrisAK, KwongPD, MascolaJR, NabelGJ, GrahamBS 2015 Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med 21:1065–1070. doi:10.1038/nm.3927.26301691

M. Sobhanie, Y. Matsuoka, Sinthujan Jegaskanda, T. Fitzgerald, R. Mallory, Zhongying Chen, C. Luke, J. Treanor, K. Subbarao (2015)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)

The Journal of Infectious Diseases, 213

R. Xu, D. Ekiert, Jens Krause, R. Hai, J. Crowe, I. Wilson (2010)

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

Science, 328

(TangG, PengL, BaldwinPR, MannDS, JiangW, ReesI, LudtkeSJ 2007 EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46. doi:10.1016/j.jsb.2006.05.009.16859925)

TangG, PengL, BaldwinPR, MannDS, JiangW, ReesI, LudtkeSJ 2007 EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46. doi:10.1016/j.jsb.2006.05.009.16859925

TangG, PengL, BaldwinPR, MannDS, JiangW, ReesI, LudtkeSJ 2007 EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46. doi:10.1016/j.jsb.2006.05.009.16859925, TangG, PengL, BaldwinPR, MannDS, JiangW, ReesI, LudtkeSJ 2007 EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46. doi:10.1016/j.jsb.2006.05.009.16859925

(ScolnickEM, McLeanAA, WestDJ, McAleerWJ, MillerWJ, BuynakEB 1984 Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812–2815. doi:10.1001/jama.1984.03340450028021.6232402)

ScolnickEM, McLeanAA, WestDJ, McAleerWJ, MillerWJ, BuynakEB 1984 Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812–2815. doi:10.1001/jama.1984.03340450028021.6232402, ScolnickEM, McLeanAA, WestDJ, McAleerWJ, MillerWJ, BuynakEB 1984 Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812–2815. doi:10.1001/jama.1984.03340450028021.6232402

(ScheresSH 2012 RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180:519–530. doi:10.1016/j.jsb.2012.09.006.23000701)

ScheresSH 2012 RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180:519–530. doi:10.1016/j.jsb.2012.09.006.23000701

ScheresSH 2012 RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180:519–530. doi:10.1016/j.jsb.2012.09.006.23000701, ScheresSH 2012 RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180:519–530. doi:10.1016/j.jsb.2012.09.006.23000701

(BulloughPA, HughsonFM, SkehelJJ, WileyDC 1994 Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37–43. doi:10.1038/371037a0.8072525)

BulloughPA, HughsonFM, SkehelJJ, WileyDC 1994 Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37–43. doi:10.1038/371037a0.8072525

BulloughPA, HughsonFM, SkehelJJ, WileyDC 1994 Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37–43. doi:10.1038/371037a0.8072525, BulloughPA, HughsonFM, SkehelJJ, WileyDC 1994 Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37–43. doi:10.1038/371037a0.8072525

E. Feshchenko, D. Rhodes, R. Felberbaum, Clifton McPherson, J. Rininger, Penny Post, M. Cox (2012)

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

BMC Biotechnology, 12

(HarrisA, CardoneG, WinklerDC, HeymannJB, BrecherM, WhiteJM, StevenAC 2006 Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A 103:19123–19127. doi:10.1073/pnas.0607614103.17146053)

HarrisA, CardoneG, WinklerDC, HeymannJB, BrecherM, WhiteJM, StevenAC 2006 Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A 103:19123–19127. doi:10.1073/pnas.0607614103.17146053, HarrisA, CardoneG, WinklerDC, HeymannJB, BrecherM, WhiteJM, StevenAC 2006 Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A 103:19123–19127. doi:10.1073/pnas.0607614103.17146053

(HickeyJM, HoltzKM, ManikwarP, JoshiSB, McPhersonCE, BucklandB, SrivastavaIK, MiddaughCR, VolkinDB 2014 Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage. J Pharm Sci 103:821–827. doi:10.1002/jps.23848.24425059)

HickeyJM, HoltzKM, ManikwarP, JoshiSB, McPhersonCE, BucklandB, SrivastavaIK, MiddaughCR, VolkinDB 2014 Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage. J Pharm Sci 103:821–827. doi:10.1002/jps.23848.24425059, HickeyJM, HoltzKM, ManikwarP, JoshiSB, McPhersonCE, BucklandB, SrivastavaIK, MiddaughCR, VolkinDB 2014 Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage. J Pharm Sci 103:821–827. doi:10.1002/jps.23848.24425059

(SmithGJ, BahlJ, VijaykrishnaD, ZhangJ, PoonLL, ChenH, WebsterRG, PeirisJS, GuanY 2009 Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 106:11709–11712. doi:10.1073/pnas.0904991106.19597152)

SmithGJ, BahlJ, VijaykrishnaD, ZhangJ, PoonLL, ChenH, WebsterRG, PeirisJS, GuanY 2009 Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 106:11709–11712. doi:10.1073/pnas.0904991106.19597152, SmithGJ, BahlJ, VijaykrishnaD, ZhangJ, PoonLL, ChenH, WebsterRG, PeirisJS, GuanY 2009 Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 106:11709–11712. doi:10.1073/pnas.0904991106.19597152

W. Laver, R. Valentine (1969)

Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus.

Virology, 38 1

(GethingMJ, ByeJ, SkehelJ, WaterfieldM 1980 Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature 287:301–306. doi:10.1038/287301a0.7421990)

GethingMJ, ByeJ, SkehelJ, WaterfieldM 1980 Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature 287:301–306. doi:10.1038/287301a0.7421990, GethingMJ, ByeJ, SkehelJ, WaterfieldM 1980 Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature 287:301–306. doi:10.1038/287301a0.7421990

(WebsterRG, LaverWG 1966 Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. J Immunol 96:596–605.5936287)

WebsterRG, LaverWG 1966 Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. J Immunol 96:596–605.5936287

WebsterRG, LaverWG 1966 Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. J Immunol 96:596–605.5936287, WebsterRG, LaverWG 1966 Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus. J Immunol 96:596–605.5936287

(FullerSD, BerrimanJA, ButcherSJ, GowenBE 1995 Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell 81:715–725. doi:10.1016/0092-8674(95)90533-2.7774013)

FullerSD, BerrimanJA, ButcherSJ, GowenBE 1995 Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell 81:715–725. doi:10.1016/0092-8674(95)90533-2.7774013, FullerSD, BerrimanJA, ButcherSJ, GowenBE 1995 Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell 81:715–725. doi:10.1016/0092-8674(95)90533-2.7774013

(LamTT, ZhouB, WangJ, ChaiY, ShenY, ChenX, MaC, HongW, ChenY, ZhangY, DuanL, ChenP, JiangJ, ZhangY, LiL, PoonLL, WebbyRJ, SmithDK, LeungGM, PeirisJS, HolmesEC, GuanY, ZhuH 2015 Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522:102–105. doi:10.1038/nature14348.25762140)

LamTT, ZhouB, WangJ, ChaiY, ShenY, ChenX, MaC, HongW, ChenY, ZhangY, DuanL, ChenP, JiangJ, ZhangY, LiL, PoonLL, WebbyRJ, SmithDK, LeungGM, PeirisJS, HolmesEC, GuanY, ZhuH 2015 Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522:102–105. doi:10.1038/nature14348.25762140, LamTT, ZhouB, WangJ, ChaiY, ShenY, ChenX, MaC, HongW, ChenY, ZhangY, DuanL, ChenP, JiangJ, ZhangY, LiL, PoonLL, WebbyRJ, SmithDK, LeungGM, PeirisJS, HolmesEC, GuanY, ZhuH 2015 Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522:102–105. doi:10.1038/nature14348.25762140

(WuCY, ChangCY, MaHH, WangCW, ChenYT, HsiaoPW, ChangCC, ChanCH, LiuCC, ChenJR 2014 Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. Vaccine 32:4485–4494. doi:10.1016/j.vaccine.2014.06.043.24962757)

WuCY, ChangCY, MaHH, WangCW, ChenYT, HsiaoPW, ChangCC, ChanCH, LiuCC, ChenJR 2014 Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. Vaccine 32:4485–4494. doi:10.1016/j.vaccine.2014.06.043.24962757, WuCY, ChangCY, MaHH, WangCW, ChenYT, HsiaoPW, ChangCC, ChanCH, LiuCC, ChenJR 2014 Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. Vaccine 32:4485–4494. doi:10.1016/j.vaccine.2014.06.043.24962757

M. Kanekiyo, Chih-Jen Wei, H. Yassine, P. McTamney, J. Boyington, J. Whittle, Srinivas Rao, W. Kong, Lingshu Wang, G. Nabel (2013)

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

Nature, 499

(GartenRJ, DavisCT, RussellCA, ShuB, LindstromS, BalishA, SessionsWM, XuX, SkepnerE, DeydeV, Okomo-AdhiamboM, GubarevaL, BarnesJ, SmithCB, EmerySL, HillmanMJ, RivaillerP, SmagalaJ, de GraafM, BurkeDF, FouchierRA, PappasC, Alpuche-ArandaCM, Lopez-GatellH, OliveraH, LopezI, MyersCA, FaixD, BlairPJ, YuC, KeeneKM, DotsonPDJr, BoxrudD, SambolAR, AbidSH, St GeorgeK, BannermanT, MooreAL, StringerDJ, BlevinsP, Demmler-HarrisonGJ, GinsbergM, KrinerP, WatermanS, SmoleS, GuevaraHF, BelongiaEA, ClarkPA, BeatriceST, DonisR, KatzJ, FinelliL, BridgesCB, ShawM, JerniganDB, UyekiTM, SmithDJ, KlimovAL, CoxNJ 2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201. doi:10.1126/science.1176225.19465683)

GartenRJ, DavisCT, RussellCA, ShuB, LindstromS, BalishA, SessionsWM, XuX, SkepnerE, DeydeV, Okomo-AdhiamboM, GubarevaL, BarnesJ, SmithCB, EmerySL, HillmanMJ, RivaillerP, SmagalaJ, de GraafM, BurkeDF, FouchierRA, PappasC, Alpuche-ArandaCM, Lopez-GatellH, OliveraH, LopezI, MyersCA, FaixD, BlairPJ, YuC, KeeneKM, DotsonPDJr, BoxrudD, SambolAR, AbidSH, St GeorgeK, BannermanT, MooreAL, StringerDJ, BlevinsP, Demmler-HarrisonGJ, GinsbergM, KrinerP, WatermanS, SmoleS, GuevaraHF, BelongiaEA, ClarkPA, BeatriceST, DonisR, KatzJ, FinelliL, BridgesCB, ShawM, JerniganDB, UyekiTM, SmithDJ, KlimovAL, CoxNJ 2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201. doi:10.1126/science.1176225.19465683, GartenRJ, DavisCT, RussellCA, ShuB, LindstromS, BalishA, SessionsWM, XuX, SkepnerE, DeydeV, Okomo-AdhiamboM, GubarevaL, BarnesJ, SmithCB, EmerySL, HillmanMJ, RivaillerP, SmagalaJ, de GraafM, BurkeDF, FouchierRA, PappasC, Alpuche-ArandaCM, Lopez-GatellH, OliveraH, LopezI, MyersCA, FaixD, BlairPJ, YuC, KeeneKM, DotsonPDJr, BoxrudD, SambolAR, AbidSH, St GeorgeK, BannermanT, MooreAL, StringerDJ, BlevinsP, Demmler-HarrisonGJ, GinsbergM, KrinerP, WatermanS, SmoleS, GuevaraHF, BelongiaEA, ClarkPA, BeatriceST, DonisR, KatzJ, FinelliL, BridgesCB, ShawM, JerniganDB, UyekiTM, SmithDJ, KlimovAL, CoxNJ 2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201. doi:10.1126/science.1176225.19465683

(1983)

Changes in the antigenicity McCraw et al

(ShiY, ZhangW, WangF, QiJ, WuY, SongH, GaoF, BiY, ZhangY, FanZ, QinC, SunH, LiuJ, HaywoodJ, LiuW, GongW, WangD, ShuY, WangY, YanJ, GaoGF 2013 Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342:243–247. doi:10.1126/science.1242917.24009358)

ShiY, ZhangW, WangF, QiJ, WuY, SongH, GaoF, BiY, ZhangY, FanZ, QinC, SunH, LiuJ, HaywoodJ, LiuW, GongW, WangD, ShuY, WangY, YanJ, GaoGF 2013 Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342:243–247. doi:10.1126/science.1242917.24009358, ShiY, ZhangW, WangF, QiJ, WuY, SongH, GaoF, BiY, ZhangY, FanZ, QinC, SunH, LiuJ, HaywoodJ, LiuW, GongW, WangD, ShuY, WangY, YanJ, GaoGF 2013 Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342:243–247. doi:10.1126/science.1242917.24009358

Peter Lee, I. Wilson (2015)

Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

Current topics in microbiology and immunology, 386

(PushkoP, PujanauskiLM, SunX, PearceM, HidajatR, KortT, SchwartzmanLM, TretyakovaI, ChunqingL, TaubenbergerJK, TumpeyTM 2015 Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus. Vaccine 33:4975–4982. doi:10.1016/j.vaccine.2015.07.026.26207590)

PushkoP, PujanauskiLM, SunX, PearceM, HidajatR, KortT, SchwartzmanLM, TretyakovaI, ChunqingL, TaubenbergerJK, TumpeyTM 2015 Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus. Vaccine 33:4975–4982. doi:10.1016/j.vaccine.2015.07.026.26207590, PushkoP, PujanauskiLM, SunX, PearceM, HidajatR, KortT, SchwartzmanLM, TretyakovaI, ChunqingL, TaubenbergerJK, TumpeyTM 2015 Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus. Vaccine 33:4975–4982. doi:10.1016/j.vaccine.2015.07.026.26207590

(McLellanJS, ChenM, LeungS, GraepelKW, DuX, YangY, ZhouT, BaxaU, YasudaE, BeaumontT, KumarA, ModjarradK, ZhengZ, ZhaoM, XiaN, KwongPD, GrahamBS 2013 Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340:1113–1117. doi:10.1126/science.1234914.23618766)

McLellanJS, ChenM, LeungS, GraepelKW, DuX, YangY, ZhouT, BaxaU, YasudaE, BeaumontT, KumarA, ModjarradK, ZhengZ, ZhaoM, XiaN, KwongPD, GrahamBS 2013 Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340:1113–1117. doi:10.1126/science.1234914.23618766, McLellanJS, ChenM, LeungS, GraepelKW, DuX, YangY, ZhouT, BaxaU, YasudaE, BeaumontT, KumarA, ModjarradK, ZhengZ, ZhaoM, XiaN, KwongPD, GrahamBS 2013 Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340:1113–1117. doi:10.1126/science.1234914.23618766

(NgwutaJO, ChenM, ModjarradK, JoyceMG, KanekiyoM, KumarA, YassineHM, MoinSM, KillikellyAM, ChuangGY, DruzA, GeorgievIS, RundletEJ, SastryM, Stewart-JonesGB, YangY, ZhangB, NasonMC, CapellaC, PeeplesME, LedgerwoodJE, McLellanJS, KwongPD, GrahamBS 2015 Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med 7:309ra162. doi:10.1126/scitranslmed.aac4241.)

NgwutaJO, ChenM, ModjarradK, JoyceMG, KanekiyoM, KumarA, YassineHM, MoinSM, KillikellyAM, ChuangGY, DruzA, GeorgievIS, RundletEJ, SastryM, Stewart-JonesGB, YangY, ZhangB, NasonMC, CapellaC, PeeplesME, LedgerwoodJE, McLellanJS, KwongPD, GrahamBS 2015 Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med 7:309ra162. doi:10.1126/scitranslmed.aac4241., NgwutaJO, ChenM, ModjarradK, JoyceMG, KanekiyoM, KumarA, YassineHM, MoinSM, KillikellyAM, ChuangGY, DruzA, GeorgievIS, RundletEJ, SastryM, Stewart-JonesGB, YangY, ZhangB, NasonMC, CapellaC, PeeplesME, LedgerwoodJE, McLellanJS, KwongPD, GrahamBS 2015 Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med 7:309ra162. doi:10.1126/scitranslmed.aac4241.

(WilsonIA, SkehelJJ, WileyDC 1981 Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366–373. doi:10.1038/289366a0.7464906)

WilsonIA, SkehelJJ, WileyDC 1981 Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366–373. doi:10.1038/289366a0.7464906

WilsonIA, SkehelJJ, WileyDC 1981 Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366–373. doi:10.1038/289366a0.7464906, WilsonIA, SkehelJJ, WileyDC 1981 Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366–373. doi:10.1038/289366a0.7464906

John Hickey, Kathy Holtz, Prakash Manikwar, S. Joshi, Clifton McPherson, B. Buckland, I. Srivastava, C. Middaugh, D. Volkin (2014)

Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage.

Journal of pharmaceutical sciences, 103 3

(LowyDR 2016 HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest 126:5–11. doi:10.1172/JCI85446.26727228)

LowyDR 2016 HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest 126:5–11. doi:10.1172/JCI85446.26727228

LowyDR 2016 HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest 126:5–11. doi:10.1172/JCI85446.26727228, LowyDR 2016 HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest 126:5–11. doi:10.1172/JCI85446.26727228

(Aguilar-YáñezJM, Portillo-LaraR, Mendoza-OchoaGI, García-EchauriSA, López-PachecoF, Bulnes-AbundisD, Salgado-GallegosJ, Lara-MayorgaIM, Webb-VargasY, León-AngelFO, Rivero-ArandaRE, Oropeza-AlmazánY, Ruiz-PalaciosGM, Zertuche-GuerraMI, DuBoisRM, WhiteSW, Schultz-CherryS, RussellCJ, AlvarezMM 2010 An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5:e11694. doi:10.1371/journal.pone.0011694.20661476)

Aguilar-YáñezJM, Portillo-LaraR, Mendoza-OchoaGI, García-EchauriSA, López-PachecoF, Bulnes-AbundisD, Salgado-GallegosJ, Lara-MayorgaIM, Webb-VargasY, León-AngelFO, Rivero-ArandaRE, Oropeza-AlmazánY, Ruiz-PalaciosGM, Zertuche-GuerraMI, DuBoisRM, WhiteSW, Schultz-CherryS, RussellCJ, AlvarezMM 2010 An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5:e11694. doi:10.1371/journal.pone.0011694.20661476, Aguilar-YáñezJM, Portillo-LaraR, Mendoza-OchoaGI, García-EchauriSA, López-PachecoF, Bulnes-AbundisD, Salgado-GallegosJ, Lara-MayorgaIM, Webb-VargasY, León-AngelFO, Rivero-ArandaRE, Oropeza-AlmazánY, Ruiz-PalaciosGM, Zertuche-GuerraMI, DuBoisRM, WhiteSW, Schultz-CherryS, RussellCJ, AlvarezMM 2010 An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5:e11694. doi:10.1371/journal.pone.0011694.20661476

Tokiko Watanabe, Maki Kiso, S. Fukuyama, N. Nakajima, M. Imai, Shinya Yamada, S. Murakami, S. Yamayoshi, K. Iwatsuki-Horimoto, Y. Sakoda, E. Takashita, Ryan McBride, T. Noda, M. Hatta, H. Imai, Dongmin Zhao, N. Kishida, Masayuki Shirakura, R. Vries, Shintaro Shichinohe, M. Okamatsu, Tomokazu Tamura, Yuriko Tomita, N. Fujimoto, K. Goto, H. Katsura, Eiryo Kawakami, I. Ishikawa, Shinji Watanabe, Mutsumi Ito, Yuko Sakai-Tagawa, Yukihiko Sugita, R. Uraki, Reina Yamaji, A. Eisfeld, Gongxun Zhong, Shufang Fan, Jihui Ping, E. Maher, A. Hanson, Y. Uchida, Takehiko Saito, M. Ozawa, G. Neumann, H. Kida, T. Odagiri, J. Paulson, H. Hasegawa, M. Tashiro, Y. Kawaoka (2013)

Characterization of H7N9 influenza A viruses isolated from humans

Nature, 501

Jian-fang Zhou, Dayan Wang, R. Gao, Baihui Zhao, Jingdong Song, X. Qi, Yanjun Zhang, Yonglin Shi, Lei Yang, Wenfei Zhu, T. Bai, K. Qin, Y. Lan, Shu-mei Zou, Jun-feng Guo, Jie Dong, Li-bo Dong, Ye Zhang, He-jiang Wei, Xiaodan Li, Jian Lu, Li-qi Liu, Xiang-rong Zhao, Xi-yan Li, Wei-juan Huang, L. Wen, H. Bo, L. Xin, Yongkun Chen, Cuilin Xu, Y. Pei, Yue Yang, Xiaodong Zhang, Shiwen Wang, Zijian Feng, Jun Han, Weizhong Yang, G. Gao, Guizhen Wu, De-xin Li, Yu Wang, Y. Shu (2013)

Biological features of novel avian influenza A (H7N9) virus

Nature, 499

B. Buckland, R. Boulanger, Mireli Fino, I. Srivastava, Kathy Holtz, N. Khramtsov, Clifton McPherson, J. Meghrous, P. Kubera, M. Cox (2014)

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

Vaccine, 32 42

(ZhouJ, WangD, GaoR, ZhaoB, SongJ, QiX, ZhangY, ShiY, YangL, ZhuW, BaiT, QinK, LanY, ZouS, GuoJ, DongJ, DongL, ZhangY, WeiH, LiX, LuJ, LiuL, ZhaoX, LiX, HuangW, WenL, BoH, XinL, ChenY, XuC, PeiY, YangY, ZhangX, WangS, FengZ, HanJ, YangW, GaoGF, WuG, LiD, WangY, ShuY 2013 Biological features of novel avian influenza A (H7N9) virus. Nature 499:500–503. doi:10.1038/nature12379.23823727)

ZhouJ, WangD, GaoR, ZhaoB, SongJ, QiX, ZhangY, ShiY, YangL, ZhuW, BaiT, QinK, LanY, ZouS, GuoJ, DongJ, DongL, ZhangY, WeiH, LiX, LuJ, LiuL, ZhaoX, LiX, HuangW, WenL, BoH, XinL, ChenY, XuC, PeiY, YangY, ZhangX, WangS, FengZ, HanJ, YangW, GaoGF, WuG, LiD, WangY, ShuY 2013 Biological features of novel avian influenza A (H7N9) virus. Nature 499:500–503. doi:10.1038/nature12379.23823727, ZhouJ, WangD, GaoR, ZhaoB, SongJ, QiX, ZhangY, ShiY, YangL, ZhuW, BaiT, QinK, LanY, ZouS, GuoJ, DongJ, DongL, ZhangY, WeiH, LiX, LuJ, LiuL, ZhaoX, LiX, HuangW, WenL, BoH, XinL, ChenY, XuC, PeiY, YangY, ZhangX, WangS, FengZ, HanJ, YangW, GaoGF, WuG, LiD, WangY, ShuY 2013 Biological features of novel avian influenza A (H7N9) virus. Nature 499:500–503. doi:10.1038/nature12379.23823727

P. Gross, F. Ennis (1977)

Influenza vaccine: split-product versus whole-virus types--How do they differ.

The New England journal of medicine, 296 10

W. Laver, W. Gerhard, R. Webster, M. Frankel, G. Air (1979)

Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies.

Proceedings of the National Academy of Sciences of the United States of America, 76 3

L. Jackson, J. Campbell, S. Frey, Kathryn Edwards, W. Keitel, K. Kotloff, Andrea Berry, Irene Graham, R. Atmar, C. Creech, I. Thomsen, Shital Patel, Andres Gutierrez, E. Anderson, H. Sahly, H. Hill, D. Noah, A. Bellamy (2015)

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

JAMA, 314 3

R. Russell, S. Gamblin, L. Haire, D. Stevens, B. Xiao, Y. Ha, J. Skehel (2004)

H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.

Virology, 325 2

J. Skehel, P. Bayley, E. Brown, S. Martin, M. Waterfield, J. White, I. Wilson, D. Wiley (1982)

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

Proceedings of the National Academy of Sciences of the United States of America, 79 4

(FeshchenkoE, RhodesDG, FelberbaumR, McPhersonC, RiningerJA, PostP, CoxMM 2012 Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 12:77. doi:10.1186/1472-6750-12-77.23110350)

FeshchenkoE, RhodesDG, FelberbaumR, McPhersonC, RiningerJA, PostP, CoxMM 2012 Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 12:77. doi:10.1186/1472-6750-12-77.23110350, FeshchenkoE, RhodesDG, FelberbaumR, McPhersonC, RiningerJA, PostP, CoxMM 2012 Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 12:77. doi:10.1186/1472-6750-12-77.23110350

E. Pettersen, Thomas Goddard, Conrad Huang, Gregory Couch, Daniel Greenblatt, E. Meng, T. Ferrin (2004)

UCSF Chimera—A visualization system for exploratory research and analysis

Journal of Computational Chemistry, 25

(WebsterRG, BrownLE, JacksonDC 1983 Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology 126:587–599. doi:10.1016/S0042-6822(83)80015-4.6190310)

WebsterRG, BrownLE, JacksonDC 1983 Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology 126:587–599. doi:10.1016/S0042-6822(83)80015-4.6190310

WebsterRG, BrownLE, JacksonDC 1983 Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology 126:587–599. doi:10.1016/S0042-6822(83)80015-4.6190310, WebsterRG, BrownLE, JacksonDC 1983 Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology 126:587–599. doi:10.1016/S0042-6822(83)80015-4.6190310

W. Mcaleer, E. Buynak, R. Maigetter, D. Wampler, W. Miller, M. Hilleman (1984)

Human hepatitis B vaccine from recombinant yeast

Nature, 307

Y. She, K. Cheng, A. Farnsworth, Xuguang Li, T. Cyr (2013)

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone*

Proteomics, 13

(LiljeroosL, KrzyzaniakMA, HeleniusA, ButcherSJ 2013 Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A 110:11133–11138. doi:10.1073/pnas.1309070110.23776214)

LiljeroosL, KrzyzaniakMA, HeleniusA, ButcherSJ 2013 Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A 110:11133–11138. doi:10.1073/pnas.1309070110.23776214, LiljeroosL, KrzyzaniakMA, HeleniusA, ButcherSJ 2013 Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A 110:11133–11138. doi:10.1073/pnas.1309070110.23776214

H. Lünsdorf, Chandrasekhar Gurramkonda, Ahmad Adnan, N. Khanna, U. Rinas (2011)

Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen

Microbial Cell Factories, 10

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms